Maj Gen (R) Masood Anwar. Bone marrow failure syndromes can be defined as a group of diseases in which occurs failure on the part of bone marrow to produce.

Slides:



Advertisements
Similar presentations
The lymphatic system and immunity
Advertisements

Acquired Aplastic Anaemia – Trends in treatment and Bone Marrow Transplantation Vikas Gupta, MD Blood and Marrow Transplant Program Princess Margaret Hospital.
AN APPROACH TO THE ANEMIC PATIENT Martin H. Ellis MD Meir Hospital 2007.
APLASTIC AND HYPOPLASTIC ANEMIAS
Normocytic Anemia Dr. Fatin Al-Sayes, MD, MSc, MRCPath Consultant Hematology / Assistant Professor King Abdulaziz University Hospital.
Faculty of Applied Medical Sciences Department Of Medical Lab. Technology 2 nd Year – Level 4 – AY Mr. Waggas Ela’as, M.Sc, MLT.
Anemia Dr. Meg-angela Christi M. Amores. What is Hematopoeisis? It is the process by which the formed elements of the blood are produced Erythropoeisis:
ANEMIA DEFINITION & CLASSIFICATION
Lecture – 3 Dr. Zahoor Ali Shaikh
APLASTIC ANEMIA BY- DR. ABHISHEK SINGH MD ASSTT. PROFESSOR DEPTT. OF MEDICINE.
MLAB Hematology Keri Brophy-Martinez
Aplastic Anemia Rakesh Biswas
Acute leukemia Mohammed Al-matrafi.
Course title: Hematology (1) Course code: MLHE-201 Supervisor: Prof. Dr Magda Sultan Outcome : The student will know : -The causes and pathogenesis of.
Blood Physiology Allison Gourley and Susan Rutherford.
Hemostatic System - general information Normal hemostatic system –vessel wall –circulating blood platelets –blood coagulation and fibrynolysis Platelets.
Normocytic Normochromic Anemias
Aplastic Anemia Failure of the bone marrow percursors to produce mature cells. Characterized by hypocellular marrow and pancytopenia. Etiology: Acquired:
Iron deficiency anemia Tsila Zuckerman. Anemia Definition : Decreased RBC mass and HB concentration Anemia is a result of imbalance between between RBC.
Thrombocytopenia Dr S W Bokhari Consultant Haematologist University Hospital Coventry and Warwickshire.
Autoimmunity. Autoimmunity :  Autoimmunity : The immune response which is directed against host tissue self epitopes due to loss of tolerance.  Self-Tolerance:
WHAT ARE THE COMPONENTS OF THE BLOOD, AND WHERE ARE THEY MADE? Plasma: proteins made mainly in liver Serum is the fluid that remains after blood clots.
Marrow Failure Kathryn Scharbach Marrow failure syndromes & diseases Multilineage Failure Fanconi anemia Fanconi anemia dyskeratosis congenita dyskeratosis.
Myelodysplastic syndromes
Aplastic Anemia Tissue Conference 1/19/00 Brad Kahl, MD.
Aplastic anemia. Definition Panctopenia with hypocellularity A rare and serious condition, aplastic anemia can develop at any age, though it's most common.
APLASTIC ANEMIA.
Lecture 2 Red Blood Cells, Anemias & Polycythemias
Multiple Myeloma Definition:
Immune System.
HIV and haematology Mike Webb Division of Clinical Haematology 8 Feb 2010.
Clinical Application for Child Health Nursing NUR 327 Lecture 3-D.
 Cancer: A disease that occurs through the growth of the abnormal cells, invasion and metastasis.  Unlike normal cells, cancer cells continue to grow.
Laboratory evaluation of erythrocyte RBC Haemoglobin Packed cell volume MCV MCH MCHC RDW Reticulocyte Blood film Quantitative description of erythropoiesis.
TRANSPLANTATION & tissue rejection
ANAEMIA Outi Vehviläinen, MD Ilembula
BLOOD DISORDERS.
CLASSIFICATION OF ANEMIA
Leukaemias. Leukaemias: Malignant Disease of WBC Forming tissue or other hemopoietic elements: Lymphoblastic (ALL) Lymphoblastic (ALL)Acute Myeloid (AML)
Red Cell Turnover and Life Span 2.5 million red cells are removed from the circulation every second. BM produces 200 billion new red cells (reticulocytes)
Autoimmunity: Autoimmunity : the immune response which directed against host tissue self epitopes due to loss of tolerance. Self-Tolerance: The non-responsiveness.
HAEMATOPOIETIC STEM ELL TRANSPLANTATION (HSCT) A process in which abnormal, malignant, or non- functioning marrow cells are replaced with normal marrow.
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 25 Blood Cells and the Hematopoietic System.
Diagnostic Approaches To Anemia 1. Is the patient anemic ? 2. How severe is the anemia ? 3. What type of anemia ? 4. Why is the patient anemic? 5. What.
Approach to Anemia Sadie T. Velásquez, M.D.. Objectives.
AN APPROACH TO THE ANEMIC PATIENT. Prevalence and causes of anemia world-wide Blood 2014;123:615 Us More common in women Iron deficiency most common cause.
Is the early cyclosporine A level predictive of the outcome of immunosuppressive therapy in severe aplastic anemia? Eur J Haematol Feb. R2 이 홍 주.
APLASTIC AND HYPOPLASTIC ANEMIAS Waggas Elaas. APLASTIC ANEMIA Aplastic anemia is a severe, life threatening syndrome in which production of erythrocytes,
MLAB Hematology Keri Brophy-Martinez
Classification of Anaemia
Acquired Hemolytic Anemias
State University of Medicine and Pharmacy "Nicolae Testemitanu“ Departmen of pediatric Subject : Aplastic anemia Amaria Ibrahem Group m1249 presented to.
Anemia of Chronic Disease
MLAB Hematology Keri Brophy-Martinez
Treatment of Aplastic Anemia
Anemia Definition Physiological Pathological Classification:
MLAB 1415-Hematology Keri Brophy-Martinez
MLAB Hematology Keri Brophy-Martinez
Immune System Chapter 43 AP/IB Biology.
APLASTIC ANAEMIA Primary idiopathic acquired aplastic anaemia: The basic problem is failure of the pluripotent stem cells, producing hypoplasia of the.
Anemia By: Dr Sunita Mittal.
MLAB 1415-Hematology Keri Brophy-Martinez
Constituents of the blood: Red and white blood cells
Immunodeficiencies.
The lymphatic system and immunity
CLASSIFICATION OF ANEMIAS
Case Presentation Diagnostic Hematology
The Lymphatic System Pages
Myelodysplastic syndromes
Blood and Lymphatic Systems
Presentation transcript:

Maj Gen (R) Masood Anwar

Bone marrow failure syndromes can be defined as a group of diseases in which occurs failure on the part of bone marrow to produce mature and functional blood cells in required quantities. In peripheral blood it will manifest as pancytopenia, bicytopenia or some times monocytopenia.

 Suppression of normal bone marrow maturation (ineffective haemopoiesis)  Destruction or suppression of stem cells and/or microenvironment  Replacement of normal bone marrow with abnormal tissue or cells  Destruction of bone marrow with disease

 Most common cause is ineffective haemopoiesis because of Vitamin B12 and/or Folate deficiency – 29%  Aplastic anaemia – 22-27%  All other causes for remaining <50%

Aplastic Anaemia is defined as pancytopenia in the peripheral blood with hypoplastic bone marrow and no evidence of any primary disease infiltrating, replacing or suppressing active haematopoiesis.

APLASTIC ANAEMIA

 Abnormalities of Stem cell  Abnormalities of Stroma  Abnormalities of cytokines

◦ Failure of stem cells to grow in normal culture ◦ Failure of normal stem cells to grow in patient stromal cell culture ◦ High CSF releaser levels ◦ Decreased response of stem cells to CSF and EPO

EXTRINSIC AGENT INTRINSIC DEFECT SILENT IMMUNE MILD TO MODERATE AUTOREACTIVITY ACUTE DESTRUCTION

 Direct Injury (Secondary or Acquired) ◦ Drugs (Iatrogenic), radiation, viruses ◦ Drug toxicity is through intermediate metabolites ◦ Bind covalently to marrow cell proteins and DNA leading to DNA damage and apoptosis ◦ Radiation causes direct damage to DNA ◦ Viruses intercalate with DNA

 Immune Mediated (idiopathic) ◦ Improvement in pancytopenia after failed allogeneic BMT  Immunosuppressive conditioning (ALG or Cyclophosphamide) intended to allow engraftment of donor marrow might have promoted the function of host marrow*  BMT of an identical twin also requires immunosuppression

 Immune Mediated (idiopathic) ◦ Improvement in pancytopenia after failed allogeneic BMT  Immunosuppressive conditioning (ALG or Cyclophosphamide) intended to allow engraftment of donor marrow might have promoted the function of host marrow*  BMT of an identical twin also requires immunosuppression

 Immune Mediated (idiopathic) ◦ Trials of IST (Immunosuppressive Therapy) ◦ Most successful regimens have been multi-drug combinations ◦ Effectiveness of such trials strongly suggest immune mediated cause of the disease

 Congenital  Acquired

 Skeletal ◦ Short stature ◦ Microcephaly ◦ Radial anamolies ◦ Hip and spine anamolies  Skin ◦ Hyperpigmentation ◦ Hypopigmentation  Genitiurinary tract ◦ Renal tract anamolies ◦ Hypogonadism  Craniofacial  Gastrointestinal  Cardiac  No associated abnormalities

SHORT STATURE

RADIAL ABNORMALITIES

RENAL ANAMOLIES

 Primary Idiopathic  Secondry ◦ PNH ◦ Radiation ◦ Chemicals ◦ Viruses ◦ Drugs  Regularly causing – cytotoxic  Probably causing – chloramphenicol  Rarely causing – Quinine etc ◦ Stroma and growth factors

 Low Hb/Hct, TLC and platelet count defined for the age and sex together with hypocellular marrow  Conveniently divided into three groups for therapeutic decisions  Non Severe Aplastic Anaemia (NSAA)  Severe Aplastic Anaemia (SAA)  Very Severe Aplastic Anaemia (VSAA)

 Presenting complaints – anaemia, infection, bleeding  History – family, personal, occupational, drugs  Physical examination – liver, spleen, lymph nodes  Blood counts ◦ Hb <10 g/dl ◦ Neutrophil count <1.0 X 10^9/l ◦ Platelet count <100 X 10^9/l ◦ Reticulocyte count (corrected) <1% ◦ MCV ~100 fl  Bone marrow ◦ Aspirate ◦ Biopsy